New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 27, 2013
08:30 EDTAUXLAuxilium Xiaflex likely to be approved, says Stifel
Stifel thinks there is at least an 80% chance that Auxilium's Xiaflex for Peyronie’s disease will be approved by the FDA. Noting that the drug has a December 6 PDUFA date, Stifel believes the stock can "trade well into the mid-$20s" if the drug is approved. The firm keeps a Buy rating on the stock.
News For AUXL From The Last 14 Days
Check below for free stories on AUXL the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 14, 2014
08:16 EDTAUXLAuxilium management to meet with UBS
Subscribe for More Information
April 11, 2014
07:06 EDTAUXLVIVUS announces avanafil clinical data presentation
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use